SALLY ABARE: Open Payments
NPI 1912583253 · NEW BRAUNFELS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$325 in 17 payments from 6 companies in 2025. Trend: 2023 $17 · 2024 $83 · 2025 $325
Food & beverage: $325
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 6 | $115 |
| Amgen Inc. | 5 | $82 |
| PFIZER INC. | 3 | $53 |
| Alnylam Pharmaceuticals Inc. | 1 | $32 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $25 |
| Boston Scientific Corporation | 1 | $18 |
Products named: LEQVIO, REPATHA, ELIQUIS, AMVUTTRA, Kerendia, WATCHMAN FLX, VYNDAQEL.
Industry payments across TX — which companies pay providers there.
